Novartis Agrees to Acquire Excellergy, Building on Allergy Leadership With Next-Generation Anti-Ige Innovation Read more
Novartis to Acquire Tourmaline Bio, Complementing Cardiovascular Pipeline With Pacibekitug for the Treatment of Atherosclerotic Cardiovascular Disease (ASCVD) Read more